Government Shutdown Changes

What has changed due to the Government Shutdown?

It’s pandemic-era flexibilities that will come to an end:

  • Geographic restrictions that only permitted telehealth in medically underserved areas
  • Requiring the patient to go to an originating site (a health care facility) instead of being in their homes
  • Allowing therapists (PTs, OTs, SLPS, audiologists) to perform services via telehealth

Behavioral health via telehealth will still be allowed after September 30th, because Congress passed a law allowing it permanently. It won’t be affected by a government shutdown, if one occurs. The Social Security Act references “mental health” as opposed to “behavioral”.
 
Quoting the MLN Matters Article on E/M services
MLN006764 September 2025
 
Telehealth Services
Section 2207 of the Full-Year Continuing Appropriations and Extensions Act, 2025, extended many of these flexibilities through September 30th, 2025. Starting October 1, 2025, the statutory limitations that were in place for Medicare telehealth services before the COVID-19 public health emergency (PHE) will retake effect for most telehealth services.
 
These include:

  • Geographic restrictions
  • Location restrictions on where you can provide services
  • Limitations on the scope of practitioners who can provide telehealth services

That is, telehealth as we know it to anywhere in the country, in the patient’s home ends. How do you know if you are in an underserved area, and can continue to do telehealth? Quick and easy: could your practice do telehealth before the pandemic? Yes: in all likelihood, you can continue, but remember the patient must go to an originating site, not their homes. Are you in an underserved area? Check here.
 
At CodingIntel, we have a copy of the CMS telehealth fact sheet from prior to the pandemic. It isn’t up-to-date with the list below, but it will tell you the rules for most practices in the country if a shutdown occurs.
 
Still allowed are services that weren’t implemented as a result of the pandemic.  
 
eCFR :: 42 CFR 410.78 — Telehealth services.
 
(iv) The geographic requirements specified in paragraph (b)(4) of this section do not apply to the following telehealth services:
 
(A) Home dialysis monthly ESRD-related clinical assessment services furnished on or after January 1st, 2019, at an originating site described in paragraphs (b)(3)(vi), (ix), or (x) of this section, in accordance with section 1881(b)(3)(B) of the Act; and
 
(B) Services furnished on or after January 1st, 2019, for purposes of diagnosis, evaluation, or treatment of symptoms of an acute stroke.
 
(C) Services furnished on or after July 1st, 2019, to an individual with a substance use disorder diagnosis, for purposes of treatment of a substance use disorder or a co-occurring mental health disorder.
 
(D) Services furnished on or after January 1st, 2025, for the purposes of diagnosis, evaluation, and/or treatment of a mental health disorder. Payment will not be made for a telehealth service furnished under this paragraph unless the physician or practitioner has furnished an item or service in person, without the use of telehealth, for which Medicare payment was made (or would have been made if the patient were entitled to, or enrolled for, Medicare benefits at the time the item or service is furnished) within 6 months prior to the initial telehealth service and within 6 months of any subsequent telehealth service.

Betsy


A Familiar Name Returns to Healthcare

In a landscape cluttered with brand mashups, logo overload, and forgettable names—WellThis, WellThat, PlusThis, PlusThat, and the never-ending bowl of Alphabet Soup—clarity is a breath of fresh air. Amidst the noise, we’re proud to reintroduce a name that brings familiarity, trust, and simplicity back into focus: HealthSpring

Co-pays Resuming for Certain Services

Effective 10/1/24: Co-pays will Resume for CHIP CoVid19 Services.

During the COVID-19 public health emergency, the Texas Health and Human Services Commission (HHSC) waived co-pays for COVID-19 vaccines, testing, and treatment for Children’s Health Insurance Program (CHIP) members. This waiver will end on September 30, 2024

Providers may begin collecting co-pays for COVID-19 vaccines, testing, and treatment rendered to CHIP eligible members for dates of service on or after October 1, 2024.

Superior Co-pays

Providers may not charge co-pays for mental health and substance use disorder outpatient office visits

Co-pays have been permanently removed for mental health and substance use disorder outpatient office visits to comply with federal regulations.

COVID-19 CPT vaccine and immunization codes

After the 2024 CPT book was printed, the AMA deleted 64 codes and Appendix Q.

COVID-19 Vaccines
Administration
• 90480 – Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, single dose
Vaccine Product
• 91318 – Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, 3mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use (6
months to 4 years) Pfizer
• 91319 – Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)(coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, 10mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use (5-11
years) Pfizer

• 91320 – Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, 30 mcg/0.3 mL dosage, tris-sucrose formulation, forintramuscular use (12 years and older) Pfizer
• 91321 – Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, 25 mcg/0.25mL dosage, for intramuscular use (6 months – 11 years) Moderna
• 91322 – Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, 50 mcg/0.5 mL dosage, for intramuscular use (12 years and older) Moderna

Superior Pediatric Vaccines 11/1/2023

For questions, please contact Pharmacy Provider Services 

 1-866-768-7147.

Updated: Vaccine Information

Date: 11/01/23

 

The best way to stay protected against COVID-19 and flu is by staying updated on vaccines. Superior HealthPlan would like to inform providers about current COVID-19 and flu vaccine coverage.

COVID-19 Vaccines
The United States Food and Drug Administration (FDA) approved updated versions (2023-2024 formulation) of the COVID-19 vaccines; both the Pfizer and Moderna versions were approved in September and the Novavax version was approved in early October.

The Vendor Drug Program (VDP) is still working on getting the new COVID-19 vaccines added to the pharmacy formulary with no provided ETA. Superior Medicaid and CHIP members can obtain the new COVID-19 vaccines through their medical provider in the meantime or wait and return to the pharmacy once the VDP and the Texas Health and Human Services Commission have added the new vaccines to the pharmacy benefit. Please check the VDP Product Search for the most updated coverage of vaccines.

Flu Vaccines
The 2023-2024 flu vaccine formulations were added by the VDP to the pharmacy benefit on September 1, 2023. Similar to last year’s flu season, Medicaid and CHIP members who are 3 years of age and older can obtain their flu vaccine from a participating pharmacy. All members under 3 years of age will need to obtain a flu vaccine from their medical provider.

Superior

Cigna MA on CoVid Testing Coverage and Reimbursement.

The waiver for customer cost-share for physician visits for test (both in and out of network) ended May 11, 2023. However, laboratory tests for CoVid ordered by the provider will continue to be covered with no out-of-pocket costs following the end of the PHE on May 12, 2023.

Cigna CoVid Coverage Changes

Changes in coverage effective May 12, 2023

The White House has announced their intent to end both the CoVid-19 National Emergency and Public Health Emergency (PHE) on May 11, 2023.

As a result, Cigna Commercial and Cigna Medicare Advantage plan to make the following changes on May 12, 2023:

  • Authorizations for facility-to-facility transfers will again be required.
  • Patient cost-share will apply to COVID-19 lab tests as well as antiviral and therapeutics approved by the U.S Food & Drug Administration (FDA).
  • For most benefit plans, COVID-19 vaccines will be covered at 100 percent under the preventive benefit (same as the flu shot) when customers go to an in-network provider.
  • Over-the-counter COVID-19 tests will no longer be covered.
Cigna Coverage Changes

ASK THE EXPERT

TMA RESOURCES

Ask the Expert: End of the Public Health Emergency

On March 29 via Zoom, join TMA experts in this interactive Q&A session as they discuss how best to prepare your practice for upcoming changes as the public health emergency winds down on May 11. They will discuss the impact on Medicaid coverage, telehealth, and COVID vaccines and treatments for which you can earn CME. Send your questions in advance. Register now

HHS Announces End of PHE

According to HHS.Gov Fact Sheet: COVID-19 Public Health Emergency Transition Road Map

The Public Health Emergency (PHE) for COVID-19 is scheduled to expire at the end of the day on May 22, 2023.

2023 Medicare Physician Fee Schedule Final Rule

On November 01, 2022, the Centers for Medicare & Medicaid Services (CMS) issued a final rule that includes updates and policy changes for Medicare payments under the Physician Fee Schedule (PFS), and other Medicare Part B issues, effective on or after January 1, 2023.